Skin diseases are among the most common diseases worldwide.
Approximately one third of the population is affected with a pathological skin problem during their lifetime.

In 2010, the total dermatology drug market has been valued at $26.8 billion and is estimated to grow at a CAGR of 3.7% until 2015.

This growth will slow down during subsequent years reaching an estimate volume of $37.8 billion in 2026.1
Up to 25% of total healthcare spending is for dermatology conditions. So dermatology is certainly not a niche market.

Within the five largest European Union countries (EU5) almost 70% of skin medications are prescription-only drugs.
Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024.